Thermo Fisher Q2 Earnings Preview: Analysts Revise Price Target to $553, Maintain Outperform Rating.

Thermo Fisher (TMO) price target revised to $553 from $573 by Baird analyst Catherine Ramsey Schulte, maintaining an Outperform rating ahead of Q2 earnings. The average target price for TMO is $543.15 with a high estimate of $767.00 and a low estimate of $450.00. The estimated GF Value for TMO in one year is $588.09, suggesting a 38.38% upside from the current price.

Thermo Fisher Scientific (TMO) has seen a downward revision in its price target by Baird analyst Catherine Ramsey Schulte. The new target price is set at $553, down from the previous $573, while maintaining an "Outperform" rating ahead of the company's upcoming second-quarter earnings announcement. This adjustment reflects a recalibration of expectations regarding TMO's market performance.

The average one-year price target for TMO, based on the estimates from 27 analysts, stands at $543.15, with a high estimate of $767.00 and a low estimate of $450.00. This average target implies an upside of 27.81% from the current price of $424.98 [1]. The consensus recommendation from 31 brokerage firms also indicates an "Outperform" status for TMO [1].

GuruFocus estimates that the fair value (GF Value) for TMO in one year is $588.09, suggesting a potential upside of 38.38% from the current price [2]. This estimate is based on historical multiples, past business growth, and future performance projections.

The revised price target comes as analysts prepare for TMO's Q2 earnings report, expected to be announced soon. Analysts predict that TMO will report earnings of $5.22 per share, a 2.8% decline year over year, with revenues projected to reach $10.65 billion, a 1% increase from the same quarter last year [2]. The revenue projections indicate a mixed performance across different segments, with some segments showing growth while others face challenges.

TMO's Q1 2025 results demonstrated strong financial performance, with revenue of $10.36 billion and adjusted EPS growth of 1% to $5.15 per share. The company also launched several innovative products and executed its capital deployment strategy, including a $4.1 billion acquisition agreement and $2 billion in share repurchases [1]. However, revenue in the Academic and Government segment declined due to macroeconomic conditions, and the company anticipates a $400 million revenue headwind due to US-China tariffs [1].

In conclusion, the downward revision in TMO's price target by Baird analyst Catherine Ramsey Schulte reflects a cautious outlook ahead of the company's Q2 earnings report. Despite the revision, the "Outperform" rating suggests that analysts remain optimistic about TMO's long-term prospects. Investors should closely monitor the company's earnings announcement and any updates on its financial performance and market outlook.

References:
[1] https://www.gurufocus.com/news/2987230/thermo-fisher-tmo-price-target-revised-ahead-of-q2-report-tmo-stock-news
[2] https://finance.yahoo.com/news/thermo-fisher-tmo-q2-earnings-131504323.html